In a study published last week in The New England Journal of Medicine, British drugmaker AstraZeneca said that in a late-stage trial, its drug Lynparza reduced the risk of relapse and death in breast cancer patients with certain gene mutations.
Lynparza was developed with Merck, and works to inhibit PARP, a protein that repairs DNA damage to cells — including those that are cancerous. It can be given as a maintenance therapy or an active treatment after chemotherapy. The study found that compared to a placebo, Lynparza reduced the combined risk of recurrence of breast cancer or death from any cause by 42 percent, Reuters reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Book reviews: ‘Red Scare: Blacklists, McCarthyism, and the Making of Modern America’ and ‘How to End a Story: Collected Diaries, 1978–1998’Feature A political ‘witch hunt’ and Helen Garner’s journal entries
-
The backlash against ChatGPT's Studio Ghibli filterThe Explainer The studio's charming style has become part of a nebulous social media trend
-
Why are student loan borrowers falling behind on payments?Today's Big Question Delinquencies surge as the Trump administration upends the program
-
Dark energy may not doom the universe, data suggestsSpeed Read The dark energy pushing the universe apart appears to be weakening
-
Life after space: how will Nasa's stranded astronauts cope?In the Spotlight Sunita 'Suni' Williams and Barry 'Butch' Wilmore are headed back to Earth after nine months on the ISS – but their greatest challenge may still lie ahead
-
Pharaoh's tomb discovered for first time in 100 yearsSpeed Read This is the first burial chamber of a pharaoh unearthed since Tutankhamun in 1922
-
Scientists report optimal method to boil an eggSpeed Read It takes two temperatures of water to achieve and no fancy gadgets
-
Europe records big leap in renewable energySpeed Read Solar power overtook coal for the first time
-
Blue Origin conducts 1st test flight of massive rocketSpeed Read The Jeff Bezos-founded space company conducted a mostly successful test flight of its 320-foot-tall New Glenn rocket
-
US won its war on 'murder hornets,' officials saySpeed Read The announcement comes five years after the hornets were first spotted in the US
-
Dark energy data suggest Einstein was rightSpeed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
